Cargando…

A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial

WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Asayut, Narong, Olson, Phayom Sookaneknun, Kanjanasilp, Juntip, Thanarat, Preut, Senkraigul, Bhattaraporn, Sittisarn, Chuthathip, Suksawat, Suratsawatee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963551/
https://www.ncbi.nlm.nih.gov/pubmed/35349576
http://dx.doi.org/10.1371/journal.pone.0265483
_version_ 1784678012506079232
author Asayut, Narong
Olson, Phayom Sookaneknun
Kanjanasilp, Juntip
Thanarat, Preut
Senkraigul, Bhattaraporn
Sittisarn, Chuthathip
Suksawat, Suratsawatee
author_facet Asayut, Narong
Olson, Phayom Sookaneknun
Kanjanasilp, Juntip
Thanarat, Preut
Senkraigul, Bhattaraporn
Sittisarn, Chuthathip
Suksawat, Suratsawatee
author_sort Asayut, Narong
collection PubMed
description WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists’ counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 –retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841.
format Online
Article
Text
id pubmed-8963551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89635512022-03-30 A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial Asayut, Narong Olson, Phayom Sookaneknun Kanjanasilp, Juntip Thanarat, Preut Senkraigul, Bhattaraporn Sittisarn, Chuthathip Suksawat, Suratsawatee PLoS One Research Article WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists’ counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 –retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841. Public Library of Science 2022-03-29 /pmc/articles/PMC8963551/ /pubmed/35349576 http://dx.doi.org/10.1371/journal.pone.0265483 Text en © 2022 Asayut et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Asayut, Narong
Olson, Phayom Sookaneknun
Kanjanasilp, Juntip
Thanarat, Preut
Senkraigul, Bhattaraporn
Sittisarn, Chuthathip
Suksawat, Suratsawatee
A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title_full A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title_fullStr A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title_full_unstemmed A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title_short A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
title_sort community pharmacist-led smoking cessation intervention using a smartphone app (pharmquit): a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963551/
https://www.ncbi.nlm.nih.gov/pubmed/35349576
http://dx.doi.org/10.1371/journal.pone.0265483
work_keys_str_mv AT asayutnarong acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT olsonphayomsookaneknun acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT kanjanasilpjuntip acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT thanaratpreut acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT senkraigulbhattaraporn acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT sittisarnchuthathip acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT suksawatsuratsawatee acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT asayutnarong communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT olsonphayomsookaneknun communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT kanjanasilpjuntip communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT thanaratpreut communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT senkraigulbhattaraporn communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT sittisarnchuthathip communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT suksawatsuratsawatee communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial